Cultural Corner, Health Care, Local News, Media & Communications, Technology

Lingraphica announces leadership transition: Kevin Self to succeed Andrew Gomory as CEO

PRINCETON, N.J. — (BUSINESS WIRE) — #AAC — Lingraphica, a leader in augmentative and alternative communication (AAC) devices, announced a significant leadership transition. Current Chief Operating Officer Kevin Self has assumed the role of Chief Executive Officer effective Jan. 1, 2025. He

Business, Health Care, Local News

US Food and Drug Administration approves Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) injection, for subcutaneous use in most previously approved adult, solid tumor Opdivo® (nivolumab) indications1,2

Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given over three- to five-minutes, Opdivo Qvantig demonstrated consistent efficacy and showed a comparable safety profile tointravenous Opdivo in the Phase 3 CheckMate-67T trial1,3     PRINCETON, N.J. — (BUSINESS WIRE)